Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Surgery
Share your love
IOL Selection and Expectation Management in a Hyperopic Patient With Astigmatism Considering Advanced Lenses | Ophthalmology Times
This final case discussed a 58-year-old hyperopic male with significant astigmatism and visually limiting cataracts who initially presented seeking LASIK but was determined to be a poor refractive surgery candidate. The panel reviewed corneal topography demonstrating oblique astigmatism and low…
Advanced IOL Selection in a Low Night-Driving Patient With Bilateral Cataracts | Ophthalmology Times
This segment reviews a case-based roundtable discussion focused on advanced intraocular lens (IOL) selection in cataract surgery, highlighting the importance of patient-centered decision-making. The case involved a 69-year-old retired pastor engaged in foreign mission work who presented with bilateral cataracts,…
Reimagining dry eye care: Focus on sustained tear production | Ophthalmology Times
(Image Credit: AdobeStock/Chris Tefme) With dry eye disease (DED) presenting ongoing challenges for clinicians and patients, a recent Ophthalmology Times Viewpoints panel aimed to explore practical strategies for improving management and long-term outcomes. Kendall Donaldson, MD, MS, from Bascom Palmer…
How AI is reshaping ophthalmology in 2025 and beyond | Ophthalmology Times
(Image Credit: AdobeStock/ImageFlow) Artificial intelligence (AI) continues to evolve with improved diagnostic abilities, individualized patient treatments, and enhanced surgical accuracy. Some key developments include the analysis of retinal scans that provide earlier disease detection and the ability to spot tumors…
8 things to know about aflibercept 8 mg for retinal vascular disease | Ophthalmology Times
The US Food and Drug Administration (FDA) approved aflibercept 8 mg (EYLEA HD) for the treatment of patients with macular edema following retinal vein occlusion (RVO) with up to 8-week dosing after an initial dosing period last month. The latest…
Screening for Demodex blepharitis: Integrating best practices into routine eye care | Ophthalmology Times
(Image Credit: AdobeStock) Demodex blepharitis is more common than previously thought, and proper diagnosis and management are important for effective patient care. Anne M. Zaki, MD, a cornea specialist in private practice at Desert Eye Specialists in Peoria, Arizona, moderated…
Malar edema: Perspectives from plastic surgery and ophthalmology | Ophthalmology Times
(Image Credit: AdobeStock/Alessandro Grandini) Malar edema, the collection of fluid below the infraorbital rim and over the malar eminence, presents a unique challenge to providers in aesthetics and ophthalmology.1 Despite their seemingly benign nature, the presence of malar edema or…
Spotlight on women’s health: Understanding thyroid eye disease | Ophthalmology Times
Image by Jennifer Toomey/MJH Life Sciences using AI Thyroid eye disease (TED), also known as Graves ophthalmopathy or Graves eye disease, is an autoimmune condition in which the immune system targets tissues related to the thyroid.1 This leads to inflammation…
Managing challenging pterygium removal: Amniotic membrane grafting strategies | Ophthalmology Times
(Image Credit: AdobeStock/Sangiao_Photography) Pterygium is a common ocular surface disorder characterized by a fibrovascular growth originating from the conjunctiva that extends onto the adjacent cornea (Figure).1 Its prevalence varies considerably across geographic regions. Because prolonged sun exposure is the main…
The Art and Science of Presbyopia Correction: Navigating the IOL Patient Journey | Ophthalmology Times
Presbyopia-correcting IOLs have undergone a dramatic transformation in recent years. The once-limited options for patients seeking reduced spectacle dependence after cataract surgery have evolved into a diverse and sophisticated array of IOL technologies, including trifocal, extended depth-of-focus (EDOF), small-aperture, light-adjustable,…